• 63

    (Nanowerk News) All cells protect themselves from the environment using very thin but ultra-strong membranes. In order to let useful molecules (nutrients etc.) go through the membrane, cells use ‘gatekeeper molecules’ called transporters. Researchers at the University of Copenhagen found out that these gatekeepers can now be manipulated to work longer hours by turning on a molecular switch. These findings constitute a profound contribution to our understanding of cells and may have massive implications for curing a plethora of diseases related to ‘gatekeeper molecules’, including depression, Alzheimer’s, diabetes, obesity and cancer, to name but a few. The results suggest that the switch may be a common characteristic of all types of transporters. Since these minuscule worker molecules control a vast variety of functions in cells, if the switches are standard, it may well be one of the most important discoveries in enzymology. Stamou heads a multidisciplinary team of scientists at the Nano-Science Center and Department of Chemistry at the University of Copenhagen who just published their discovery in the most recent issue of the prestigious scientific journal Science (“Direct observation of proton pumping by a eukaryotic P-type ATPase”). Switch contradicts previous understanding The discovery of the novel ‘ignition key‘ contradicts previous ideas of how cells control the function of proteins such as the proton transporter used in the current study.

    Researchers used to think that transporters work continuously. But in fact they are quite lazy. Very much like real-life gatekeepers, they work for a given amount of time – working hours – and then they shut the gates, take some time off to rest.Tripping their newfound switch resulted in doubling the working hours of the proton transporter studied by the team in Copenhagen. In proteins, function is decided by the shape of the molecule. So making them more efficient would have required a major reconstruction. In some cases so difficult that it is in the order of transforming a handsaw into a chainsaw, says Dr. Salome Veshaguri, who was deeply involved in the scrutiny of the transporters. “Changing the fundamental shape of a tool is always difficult, whether it’s a saw or a transporter. But working longer hours with the same tool is infinitely easier. What we’ve achieved is to make transporters work longer hours, and this principle can be applied to the development of new drugs”, explains Veshaguri. Scrutiny on the nanoscale Observing that transporters even have an on-off switch may sound easy, but first the Bionano team had to devise a way to study individual transporter molecules. These are so small, that there could be trillions in just a drop of water. So measuring the work of a single transporter could be compared to looking down from the moon to detect each time a gate opens and closes on a motorway tollbooth. Arrays of nanoscopic ‘balloons’ light up when transporters go to work To perform their studies, the researchers have developed a method to study one transporter molecule at a time. From a complex cell, they isolated the transporter molecule and put it into a model system – artificial nanocells. This was done in the laboratory of Professor Pomorski in Copenhagen. Within each nanocell, we placed thousands of fluorescent dyes, chemical molecules functioning as nanoscopic torches, which light up and report faithfully the ‘working hours’ of each transporter molecule. “Importantly, because the nanocells are so small (100 nm in diameter), we could study millions of them using a chip not bigger than a square millimeter”, explains Dr. Veshaguri.
     
     

    No comments

    Be the first one to leave a comment.

    Post a Comment


     

     

    Latest Posts

    Latest Video

     
     

    LATEST POSTS

    Chinese company Jala Group using 3D printed skin to test cosmetics for Asian market

    SOURCE Jala Group, a Chinese cosmetics company, has used 3D bioprinting technology to print artificial “Asian skin,” complete with dermis and…

    Historic HIV vaccine efficacy study underway in South Africa

    The first HIV vaccine efficacy study to launch anywhere in 7 years is testing whether an experimental vaccine safely prevents…

    When Pot Meets Pain and Insomnia: Why Many Fibromyalgia Patients Swear by Medical Marijuana

      Fibromyalgia is a painful condition that over three million Americans suffer from. It causes widespread muscle pain and tenderness…

    Nanoarray sniffs out and distinguishes multiple diseases

    SOURCE “Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules” ACS Nano Before modern…

    Cardiac stem cell infusion could be effective therapy for the most common type of heart failure

    SOURCE Cardiac stem cells could be an effective treatment for a common but difficult-to-treat type of heart failure, a new…

    Outer layer of human heart regrown using stem cells

    Human stem cells have been used to regenerate the cells that cover the external surface of a human heart(Credit: DarioStudios/Depositphotos) SOURCE…

    Gastrogenomic delights: A movable feast

    SOURCE The complete genome sequences of Escherichia coli and Helicobacter pylori provide insights into the biology of these species Recently,…

    Glaucoma gene therapy on positive trajectory using CRISPR-Cas9

    SOURCE May 02, 2016 Seattle—Results from a series of preclinical studies are providing proof of principle that gene targeting using…